TRACON Pharmaceuticals And Micromet Announce The Initiation Of Phase 1 Clinical Trial With TRC093 (D93), A Humanized … (Medical News Today)
TRACON Pharmaceuticals, Inc. (TRACON), a biopharmaceutical company focused on the development of products for oncology and ophthalmology treatment, and Micromet, Inc. [click link for full article]